Allelic expression imbalance of the schizophrenia susceptibility gene CHI3L1: Evidence of cis-acting variation and tissue specific regulation

Psychiatric Genetics

Volumn 21, Issue 6, 2011, Pages 281-286

  Hill, Matthew James ^a   Kenny, Elaine ^a   Roche, Siobhan ^a   Morris, Derek W ^a   Corvin, Aiden ^a   Hawi, Ziarih ^a   Gill, Michael ^a   Anney, Richard J L ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; RNA;

ALLELE; ALLELIC EXPRESSION IMBALANCE; ARTICLE; AUTOPSY; BRAIN TISSUE; CHITINASE 3 LIKE 1 GENE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOBLAST; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA; TISSUE SPECIFICITY;

ADIPOKINES; ALLELES; ALLELIC IMBALANCE; BRAIN; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HAPMAP PROJECT; HUMANS; LECTINS; LINKAGE DISEQUILIBRIUM; LYMPHOCYTES; ORGAN SPECIFICITY; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMORTEM CHANGES; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 80255137457     PISSN: 09558829     EISSN: 14735873     Source Type: Journal    
DOI: 10.1097/YPG.0b013e328348045b     Document Type: Article

References (28)

1. Arion D, Unger T, Lewis DA, Levitt P, Mirnics K (2007). Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry 62:711-721
2. Barrett JC, Fry B, Maller J, Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
3. Bray NJ, Buckland PR,Williams NM,Williams HJ, Norton N, Owen MJ, et al. (2003). A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 73:152-161.
4. Bray NJ, Jehu L, Moskvina V, Buxbaum JD, Dracheva S, Haroutunian V, et al. (2004). Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes. Hum Mol Genet 15:2885-2892.
5. Bray NJ, Holmans PA, van den Bree MB, Jones L, Elliston LA, Hughes G, et al. (2008). Cis- and trans- loci influence expression of the schizophrenia susceptibility gene DTNBP1. Hum Mol Genet 17:1169-1174.
6. Buonocore F, Hill MJ, Campbell CD, Oladimeji PB, Jeffries AR, Troakes C, et al. (2010). Effects of cis-regulatory variation differ across regions of the adult human brain. Hum Mol Genet 19:4490-4496.
7. Chung C, Tallerico T, Seeman P (2003). Schizophrenia hippocampus has elevated expression of chondrex glycoprotein gene. Synapse 50:29-34.
8. Chupp GL, Lee CG, Jarjour N, Shim YM, Holm CT, He S, et al. (2007). A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med 357:2016-2027.
9. Davidovich O, Kimmel G, Shamir R (2007). GEVALT: an integrated software tool for genotype analysis. BMC Bioinformatics 8:36.
10. Garbett K, Ebert PJ, Mitchell A, Lintas C, Manzi B, Mirnics K, et al. (2008). Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis 30:303-311.
11. Ge B, Pokholok DK, Kwan T, Grundberg E, Morcos L, Verlaan DJ, et al. (2009). Global patterns of cis variation in human cells revealed by high-density allelic expression analysis. Nat Genet 41:1216-1222.
12. Gimelbrant A, Hutchinson JN, Thompson BR, Chess A (2007). Widespread monoallelic expression on human autosomes. Science 318:1136-1140.
13. Hayesmoore JB, Bray NJ, Owen MJ, ODonovan MC (2008). DISC1 mRNA expression is not influenced by common Cis-acting regulatory polymorphisms or imprinting. Am J Med Genet B Neuropsychiatr Genet 147B:1065-1069.
14. Johansen JS, Jensen HS, Price PA (1993). A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol 32:949-955.
15. Johansen JS, Jensen BV, Roslind A, Nielsen D, Price PA (2006). Serum YKL-40, a new prognostic biomarker in cancer patients? Cancer Epidemiol Biomarkers Prev 15:194-202.
16. Junker N, Johansen JS, Hansen LT, Lund EL, Kristjansen PE (2005). Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells. Cancer Sci 96:183-190.
17. Lim JE, Papp A, Pinsonneault J, Sadée W, Saffen D (2006). Allelic expression of serotonin transporter (SERT) mRNA in human pons: lack of correlation with the polymorphism SERTLP. Mol Psychiatry 7:649-662.
18. Lim JE, Pinsonneault J, Sadee W, Saffen D (2007). Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons. Mol Psychiatry 12:491-501.
19. Ober C, Tan Z, Sun Y, Possick JD, Pan L, Nicolae R, et al. (2008). Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med 358:1682-1691.
20. Ohi K, Hashimoto R, Yasuda Y, Yoshida T, Takahashi H, Iike N, et al. (2010). The chitinase 3-like 1 gene and schizophrenia: evidence from a multi-center casecontrol study and meta-analysis. Schizophr Res 116:126-132.
21. Quinn EM, Hill M, Anney R, Gill M, Corvin AP, Morris DW (2010). Evidence for cis-acting regulation of ANK3 and CACNA1C gene expression. Bipolar Disord 12:440-445.
22. Recklies AD, Ling H,White C, Bernier SM (2005). Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes.J BiolChem280:41213-41221.
23. Sham P, Bader JS, Craig I, ODonovan M, Owen M (2002). DNA Pooling: a tool for large-scale association studies. Nat Rev Genet 3:862-871.
24. Shostak K, Labunskyy V, Dmitrenko V, Malisheva T, Shamayev M, Rozumenko V, et al. (2003). HC gp-39 gene is upregulated in glioblastomas. Cancer Lett 198:203-210.
25. Tanwar MK, Gilbert MR, Holland EC (2002). Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res 62:4364-4368.
26. Yamada K, Hattori E, Iwayama Y, Toyota T, Ohnishi T, Iwata Y, et al. (2009). Failure to confirm genetic association of the CHI3L1 gene with schizophrenia in Japanese and Chinese populations. Am J Med Genet B Neuropsychiatr Genet 150B:508-514.
27. Yang MS, Morris DW, Donohoe G, Kenny E, ODushalaine CT., Schwaiger S, et al. (2008). Chitinase-3-like 1 (CHI3L1) gene and schizophrenia: genetic association and a potential functional mechanism. Biol Psychiatry 64:98-103.
28. Zhao X, Tang R, Gao B, Shi Y, Zhou J, Guo S, et al. (2007). Functional variants in the promoter region of Chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia. Am J Hum Genet 80:12-18.